Heart Breaking Complications
Scientists have known for a while that some chemotherapy agents can cause heart disease in some patients. This complication is now being seen in some women taking a popular breast cancer drug.
Accelerated FDA Review For HER2-Positive Drug
HER2-positive breast cancer is one of the most aggressive forms of the disease. A new treatment option may soon be available to help battle this vicious cancer.
Breast Cancer Chemotherapy and Heart Problems
A common treatment for breast cancer is chemotherapy. This involves using different drugs to kill cancer cells wherever they are in the body. Two commonly used chemotherapy drugs have some dangerous side effects.
Smart Bomb for HER2+ Breast Cancer
HER2-positive breast cancer is one of the most aggressive forms of the disease. It tends to grow and spread rapidly. An experimental drug may halt this beast and offer a gentler ride for women living with it .
A Hearty Defense Against Chemo's Harm
Cancer treatment is frequently a delicate balance between too much and not enough. Part of the therapy includes careful evaluation of how the patient is handling the side effects.
A One-Two Punch Knocks HER2 Out
Cancer researchers are doing more with existing drugs - looking for other applications of some and combining therapies. A combination cocktail seems to work well with HER2-positive breast cancer.
HER2 Doesn't Like Extra Lbs
Obesity has been a major topic at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. Excess weight has been shown to be an aggravating factor on a number of fronts. Now, obesity is known to complicate the treatment of HER2-postive breast cancer.
Brighter Path for HER-2 Positive Breast Cancer
One of the mainstay drugs to treat aggressive breast cancer is very toxic and can cause serious long-term heart problems. A new study has uncovered a treatment regimen that's just effective, but far less toxic.
New Therapy for HER2-Positive Breast Cancer?
Herceptin (trastuzumab) has revolutionized the treatment of HER2-positive breast cancer. However, some patients become resistant to the drug. Now, there's new hope for these women.
Getting Cancer Drugs to Market Faster
The U.S. Food and Drug Administration (FDA) has plenty of detractors. It's accused of being sluggish and too cumbersome in approving new medications, especially vitally important anti-cancer medications.